Literature DB >> 19161896

Setting the standard for recovery: Physicians' Health Programs.

Robert L DuPont1, A Thomas McLellan, William L White, Lisa J Merlo, Mark S Gold.   

Abstract

A sample of 904 physicians consecutively admitted to 16 state Physicians' Health Programs (PHPs) was studied for 5 years or longer to characterize the outcomes of this episode of care and to explore the elements of these programs that could improve the care of other addicted populations. The study consisted of two phases: the first characterized the PHPs and their system of care management, while the second described the outcomes of the study sample as revealed in the PHP records. The programs were abstinence-based, requiring physicians to abstain from any use of alcohol or other drugs of abuse as assessed by frequent random tests typically lasting for 5 years. Tests rapidly identified any return to substance use, leading to swift and significant consequences. Remarkably, 78% of participants had no positive test for either alcohol or drugs over the 5-year period of intensive monitoring. At post-treatment follow-up 72% of the physicians were continuing to practice medicine. The unique PHP care management included close linkages to the 12-step programs of Alcoholics Anonymous and Narcotics Anonymous and the use of residential and outpatient treatment programs that were selected for their excellence.

Entities:  

Mesh:

Year:  2009        PMID: 19161896     DOI: 10.1016/j.jsat.2008.01.004

Source DB:  PubMed          Journal:  J Subst Abuse Treat        ISSN: 0740-5472


  26 in total

1.  Maintenance of reinforcement to address the chronic nature of drug addiction.

Authors:  Kenneth Silverman; Anthony DeFulio; Sigurdur O Sigurdsson
Journal:  Prev Med       Date:  2012-06-05       Impact factor: 4.018

2.  The Mentally Ill Physician: Issues in Assessment, Treatment and Advocacy.

Authors:  Michael F Myers; Alison Freeland
Journal:  Can J Psychiatry       Date:  2019-08-20       Impact factor: 4.356

Review 3.  Resilience training for healthcare providers: an Asian perspective.

Authors:  Florence Alice Hamou-Jennings; Chaoyan Dong
Journal:  Mhealth       Date:  2016-06-15

4.  Opioid substitution therapy for dependent health care practitioners: approach with caution.

Authors:  Paul H Earley
Journal:  Mayo Clin Proc       Date:  2012-08       Impact factor: 7.616

5.  Buprenorphine maintenance therapy in opioid-addicted health care professionals returning to clinical practice: a hidden controversy.

Authors:  Heather Hamza; Ethan O Bryson
Journal:  Mayo Clin Proc       Date:  2012-03       Impact factor: 7.616

6.  Missouri physicians do not stand alone.

Authors:  Robert Bondurant
Journal:  Mo Med       Date:  2013 Nov-Dec

7.  Mandatory naltrexone treatment prevents relapse among opiate-dependent anesthesiologists returning to practice.

Authors:  Lisa J Merlo; William M Greene; Raymond Pomm
Journal:  J Addict Med       Date:  2011-12       Impact factor: 3.702

8.  Lifetime psychiatric and substance use disorders among impaired physicians in a physicians health program: comparison to a general treatment population: psychopathology of impaired physicians.

Authors:  Linda B Cottler; Shaun Ajinkya; Lisa J Merlo; Sara Jo Nixon; Arbi Ben Abdallah; Mark S Gold
Journal:  J Addict Med       Date:  2013 Mar-Apr       Impact factor: 3.702

Review 9.  Random student drug testing as a school-based drug prevention strategy.

Authors:  Robert L DuPont; Lisa J Merlo; Amelia M Arria; Corinne L Shea
Journal:  Addiction       Date:  2012-08-20       Impact factor: 6.526

Review 10.  Neurogenetics of dopaminergic receptor supersensitivity in activation of brain reward circuitry and relapse: proposing "deprivation-amplification relapse therapy" (DART).

Authors:  Kenneth Blum; Thomas J H Chen; B William Downs; Abdalla Bowirrat; Roger L Waite; Eric R Braverman; Margaret Madigan; Marlene Oscar-Berman; Nicholas DiNubile; Eric Stice; John Giordano; Siobhan Morse; Mark Gold
Journal:  Postgrad Med       Date:  2009-11       Impact factor: 3.840

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.